Atlas Trials

Post-Market Registry to Evaluate the Safety and Efficacy of the The SUPRAFLEX CRUZ™ Sirolimus Eluting Coronary Stent System in the Treatment of an Octo- and Nonagenerian All-Comer Patient Cohort With Coronary Artery Disease - the Cruz Senior Study

Clinical trial NCT04612179 · COMPLETED

Trial details

NCT number
NCT04612179
Sponsor
IHF GmbH - Institut für Herzinfarktforschung
Status
COMPLETED
Study type
OBSERVATIONAL
Coronary Disease
Start date
2021-06-23
Primary completion
2025-06-12
Enrollment
2017

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.